Top compounds associated with response to TMEM189-UBE2V1


Feature Type Standardized
Nominal ANOVA
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.19 7e-07
mRNA barasertib CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA indisulam CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0001
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
Download CSV